New NPC Research Examines Challenges and Holistic Solutions for Improving Patient Access to Gene Therapies Read more about New NPC Research Examines Challenges and Holistic Solutions for Improving Patient Access to Gene Therapies
Improving Access to Gene Therapies: A Holistic View of Current Challenges and Future Policy Solutions in the United States Read more about Improving Access to Gene Therapies: A Holistic View of Current Challenges and Future Policy Solutions in the United States
CMS’s Drug Price Negotiation Program 2023 Patient-Focused Listening Sessions: A Descriptive Analysis of Speaker Remarks Read more about CMS’s Drug Price Negotiation Program 2023 Patient-Focused Listening Sessions: A Descriptive Analysis of Speaker Remarks
Study Finds ICER’s Shared Saving Methods Reduce Incentives for Rare, Severe, and Pediatric Disease Treatment Innovation Read more about Study Finds ICER’s Shared Saving Methods Reduce Incentives for Rare, Severe, and Pediatric Disease Treatment Innovation
The IRA May Have Unintended Consequences on Subsequent Indications of Oncology Drugs (New Research) Read more about The IRA May Have Unintended Consequences on Subsequent Indications of Oncology Drugs (New Research)
Statement from NPC's John O'Brien on CMS Announcement of Maximum Fair Price Read more about Statement from NPC's John O'Brien on CMS Announcement of Maximum Fair Price
Analyzing Accelerated Approval for Oncology Drugs: NPC Commentary Evaluates Evidence on FDA Program Effectiveness, Concludes Benefits Outweigh Risks Read more about Analyzing Accelerated Approval for Oncology Drugs: NPC Commentary Evaluates Evidence on FDA Program Effectiveness, Concludes Benefits Outweigh Risks
NPC Submits Comments on Next Steps in the 21st Century Cures Initiative Read more about NPC Submits Comments on Next Steps in the 21st Century Cures Initiative